18 August 2022 | News
The funds will drive MiyaHealth’s aggressive growth strategy across the globe, starting with Europe and Southeast Asia
Image credit: shutterstock
MiyaHealth, a Singapore-based healthtech startup, has raised an undisclosed sum in additional funding from leading healthcare and technology investors including HealthXCapital, Central Capital Ventura, and SEEDS Capital.
This comes after MiyaHealth raised $6.5 million pre-Series A in February this year, which was one of the largest pre-Series A rounds by a healthtech startup in Southeast Asia. The fresh funds will be used to accelerate the company’s product development, hiring, and expansion plans.
Following inbound investor interest, MiyaHealth is also planning to kick-off its Series A fundraise in the next six months to further develop its product suite, expand its operations globally and continue embarking on collaborations with key stakeholders moving forward.
MiyaHealth has launched a suite of products that include MiyaPatient, a patient navigation platform with a predictive and personalised system that helps patients with chronic diseases cope with daily challenges; MiyaPayor, a platform that incorporates AI-driven claims processing, provider network management and predictive analytics to reduce costs for payors; and MiyaProvider, an upcoming product that improves patients’ experience in hospitals and clinics.